FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pulmonology, and concerns a method of selecting duration of Ceruloplasmin therapy in patients with bronchial asthma. Proposed method consists in the fact that in the patients with bronchial asthma measured in blood supcrocsyd dismutase (SOD) and malonic aldehyde (MA) and their ratio MDA/SOD after treating by Ceruloplasmin in a dose of 100 mg intravenously 1 time a day for 7 days. When the ratio of MDA/SOD 5.03 Ceruloplasmin rate of antioxidant therapy is stopped, otherwise antioxidant therapy is continued for 3-4 days.
EFFECT: use of the method allows increase efficiency of therapy of bronchial asthma.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF THERAPEUTIC RESISTANCE IN PATIENTS WITH BRONCHIAL ASTHMA | 2010 |
|
RU2433401C1 |
| METHOD OF PREDICTING UNCONTROLLED COURSE OF SEVERE BRONCHIAL ASTHMA | 2011 |
|
RU2470582C1 |
| METHOD OF PROGNOSIS OF EFFICIENCY OF BRONCHIAL ASTHMA BASIC THERAPY IN CHILDREN | 2007 |
|
RU2356054C1 |
| METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
| METHOD OF CHRONIC OBSTRUCTIVE LUNG DISEASE (BRONCHIAL ASTHMA, CHRONIC OBSTRUCTIVE LUNG DISEASE) MEDICAL TREATMENT | 2006 |
|
RU2326647C2 |
| METHOD FOR PREDICTION OF RISK OF UNCONTROLLED BRONCHIAL ASTHMA | 2014 |
|
RU2559905C1 |
| METHOD OF REHABILITATION OF PATIENTS WITH BRONCHIAL ASTHMA | 2018 |
|
RU2717708C1 |
| METHOD FOR DETERMINING DEGREE OF SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2516971C1 |
| METHOD FOR REGENERATIVE TREATMENT OF PATIENTS WITH BRONCHIAL ASTHMA AND OBESITY | 2016 |
|
RU2622610C1 |
| METHOD OF MEDICAL REHABILITATION OF PATIENTS WITH PARTIALLY CONTROLLED MILD BRONCHIAL ASTHMA | 2017 |
|
RU2655543C1 |
